Compare · PRTG vs TTE
PRTG vs TTE
Side-by-side comparison of Portage Biotech Inc. (PRTG) and TotalEnergies SE (TTE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PRTG and TTE operate in Oil & Gas Production (Energy), so they compete in similar markets.
- TTE is the larger of the two at $193.75B, about 1578.3x PRTG ($122.8M).
- TTE has hit the wire 3 times in the past 4 weeks while PRTG has been quiet.
- TTE has more recent analyst coverage (25 ratings vs 5 for PRTG).
Portage Biotech Inc.
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.
TotalEnergies SE
TotalEnergies SE operates as an integrated oil and gas company worldwide. The company operates through four segments: Exploration & Production; Integrated Gas, Renewables & Power; Refining & Chemicals; and Marketing & Services. The company's Exploration & Production segment is involved in oil and natural gas exploration and production activities in approximately 50 countries. Its Integrated Gas, Renewables & Power segment engages in the liquefied natural gas (LNG) production, shipping, trading, and regasification activities; trading of liquefied petroleum gas (LPG), petcoke and sulfur, natural gas, and electricity; transportation of natural gas; electricity production from natural gas, wind, solar, hydroelectric, and biogas sources; energy storage activities; and development and operation of biomethane production units, as well as provides energy efficiency services. The company's Refining & Chemicals segment is involved in refining petrochemicals, including olefins and aromatics; and polymer derivatives, such as polyethylene, polypropylene, polystyrene, and hydrocarbon resins, as well as biomass conversion and elastomer processing. This segment also engages in trading and shipping crude oil and petroleum products. Its Marketing & Services segment produces and sells lubricants; supplies and markets petroleum products, including bulk fuel, aviation and marine fuel, special fluids, compressed natural gas, LPG, and bitumen; and provides fuel payment solutions. It operates approximately 15,500 service stations. As of December 31, 2020, the company had 12,328 Mboe of combined proved reserves of oil and gas. It has a strategic partnership with PureCycle Technologies, as well as GHGSat Inc. to develop a satellite imaging technology to monitor potential methane leak occurrences at offshore facilities. The company was formerly known as TOTAL SE and changed its name to TotalEnergies SE in June 2021. The company was incorporated in 1924 and is headquartered in Paris, France.
Latest PRTG
- SEC Form 424B3 filed by Portage Biotech Inc.
- SEC Form 6-K filed by Portage Biotech Inc.
- SEC Form 424B5 filed by Portage Biotech Inc.
- SEC Form 424B3 filed by Portage Biotech Inc.
- SEC Form 6-K filed by Portage Biotech Inc.
- AlphaTON Capital Corp Launches TON Digital Asset Treasury Strategy for the Telegram Ecosystem
- SEC Form S-8 filed by Portage Biotech Inc.
- SEC Form 424B3 filed by Portage Biotech Inc.
- SEC Form 424B3 filed by Portage Biotech Inc.
- SEC Form 6-K filed by Portage Biotech Inc.
Latest TTE
- TotalEnergies SE: Information Concerning the Total Number of Voting Rights and Shares in the Share Capital as at July 31, 2026
- SEC Form 6-K filed by TotalEnergies SE
- Renewables in Europe: TotalEnergies Acquires Shell’s Renewables Business and Sells a 50% Stake in a Portfolio of Developed Assets to KKR
- Cyprus: TotalEnergies Approves the Development of the Cronos Gas Field to Supply Europe with LNG
- TotalEnergies SE Appeals the 25 June 2026 Judgment in the Duty of Vigilance Climate Case
- TotalEnergies Publishes Its Financial Report for First Half 2026
- TD Cowen reiterated coverage on TotalEnergies SE with a new price target
- SEC Form 6-K filed by TotalEnergies SE
- TotalEnergies: Indicative Dates for 2027 Dividends
- TotalEnergies Decides the Distribution of a Second Interim Dividend of €0.90/share for Fiscal Year 2026, an Increase of 5.9% Compared to 2025